{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:56:57Z","timestamp":1793059017864,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.revmed.2025.06.014","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:34:54Z","timestamp":1752582894000},"page":"517-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Place de la chitotriosidase au sein des biomarqueurs s\u00e9riques de la sarco\u00efdose\u00a0: une revue narrative de la litt\u00e9rature"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1493-7390","authenticated-orcid":false,"given":"Patrick","family":"Merci\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visal","family":"Keo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Contis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9tienne","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-616X","authenticated-orcid":false,"given":"No\u00e9mie","family":"Gensous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-2370","authenticated-orcid":false,"given":"Guillaume","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7547-2932","authenticated-orcid":false,"given":"Vivien","family":"Guillotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-7399","authenticated-orcid":false,"given":"Estibaliz","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Aurillac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duffau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2025.06.014_bib0585","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.revmed.2025.06.014_bib0590","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risks factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0595","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors. ACCESS Research Group","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0600","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.200909-1338OC","article-title":"Smoking, use of moist snuff, and risk of chronic inflammatory diseases","volume":"181","author":"Carlens","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0605","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1378\/chest.14-1099","article-title":"Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women's Health Study","volume":"147","author":"Cozier","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0610","doi-asserted-by":"crossref","first-page":"1701815","DOI":"10.1183\/13993003.01815-2017","article-title":"Sarcoidosis mortality in Sweden: a population-based cohort study","volume":"51","author":"Rossides","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2025.06.014_bib0615","doi-asserted-by":"crossref","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2025.06.014_bib0620","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management. Longo DL, \u00e9diteur","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0625","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(75)90395-2","article-title":"Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis","volume":"59","author":"Lieberman","year":"1975","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0630","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0635","series-title":"Sarcoidosis: a clinician's guide","first-page":"219","article-title":"Biomarkers in sarcoidosis","author":"Schimmelpennink","year":"2019"},{"issue":"26","key":"10.1016\/j.revmed.2025.06.014_bib0640","article-title":"Multiple benign sarkoids of the skin","volume":"XXXIII","author":"Boeck","year":"1899","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2025.06.014_bib0645","first-page":"840","article-title":"Diagnosis and management of sarcoidosis","volume":"93","author":"Soto-Gomez","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.revmed.2025.06.014_bib0650","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0655","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/jcp.36.8.938","article-title":"Angiotensin-converting enzyme and its clinical significance-a review","volume":"36","author":"Studdy","year":"1983","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0660","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.176.4030.64","article-title":"Angiotensin I: metabolism by plasma membrane of lung","volume":"176","author":"Ryan","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.revmed.2025.06.014_bib0665","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1357-2725(02)00309-6","article-title":"The angiotensin converting enzyme (ACE)","volume":"35","author":"Coates","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0670","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.76.12.6646","article-title":"Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas","volume":"76","author":"Silverstein","year":"1979","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.revmed.2025.06.014_bib0675","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0006-291X(78)91471-7","article-title":"Induction of angiotensin converting enzyme in human monocytes in culture","volume":"83","author":"Friedland","year":"1978","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.revmed.2025.06.014_bib0680","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-93-6-825","article-title":"Serum angiotensin-converting enzyme: elevations in diabetes mellitus","volume":"93","author":"Lieberman","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0685","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-96-3-326","article-title":"Increased levels of serum angiotensin-converting enzyme activity in hyperthryroidism","volume":"96","author":"Yotsumoto","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0690","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.clinre.2011.06.008","article-title":"Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms","volume":"35","author":"Beyazit","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0695","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(78)91972-4","article-title":"Serum angiotensin-converting enzyme (SACE) in sarcoidosis and other granulomatous disorders","volume":"2","author":"Studdy","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2025.06.014_bib0700","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1378\/chest.84.5.522","article-title":"Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function","volume":"84","author":"Lieberman","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0705","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0009-9120(87)80123-6","article-title":"Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis","volume":"20","author":"Bunting","year":"1987","journal-title":"Clin Biochem"},{"key":"10.1016\/j.revmed.2025.06.014_bib0710","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1309\/AJCPNC7STHG0FWMP","article-title":"User of likelihood ratios improves interpretation of laboratory testing for pulmonary sarcoidosis","volume":"134","author":"De Smet","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0715","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/1744666X.2019.1568240","article-title":"Clinically useful serum biomarkers for diagnosis and prognosis of sarcoidosis","volume":"15","author":"Ramos-Casals","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0720","first-page":"631","article-title":"Effects of sarcoid and steroids on angiotensin-converting enzyme","volume":"128","author":"Baughman","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.revmed.2025.06.014_bib0725","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1164\/ajrccm.160.1.9809024","article-title":"Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis","volume":"160","author":"Baltzan","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0730","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.00227014","article-title":"Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis","volume":"46","author":"Vorselaars","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2025.06.014_bib0735","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"Vorselaars","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0740","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1515\/jomb-2016-0017","article-title":"Verifying sarcoidosis activity: chitotriosidase versus ACE in sarcoidosis\u2013A case-control study","volume":"35","author":"Popevi\u0107","year":"2016","journal-title":"J Med Biochem"},{"key":"10.1016\/j.revmed.2025.06.014_bib0745","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1183\/09031936.00055213","article-title":"Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis","volume":"43","author":"Vorselaars","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2025.06.014_bib0750","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1378\/chest.15-1061","article-title":"Ordering of the serum angiotensin-converting enzyme test in patients receiving angiotensin-converting enzyme inhibitor therapy: an avoidable but common error","volume":"148","author":"Krasowski","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0755","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1755-5922.2010.00252.x","article-title":"Differences in angiotensin convertase enzyme (ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgery: tissue ACE in saphenous vein and radial artery","volume":"30","author":"Darag\u00f3","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.revmed.2025.06.014_bib0760","doi-asserted-by":"crossref","first-page":"e93719","DOI":"10.1371\/journal.pone.0093719","article-title":"New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases","volume":"9","author":"Fagyas","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2025.06.014_bib0765","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0770","first-page":"A4815","article-title":"Genotyping increases the yield of angiotensin-converting enzyme in sarcoidosis\u2013a systematic review","volume":"61","author":"Floe","year":"2014","journal-title":"Dan Med J"},{"key":"10.1016\/j.revmed.2025.06.014_bib0775","doi-asserted-by":"crossref","first-page":"107553","DOI":"10.1016\/j.biotechadv.2020.107553","article-title":"Glycoside hydrolase family 18\u00a0chitinases: the known and the unknown","volume":"43","author":"Chen","year":"2020","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.revmed.2025.06.014_bib0780","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1369\/jhc.4A6547.2005","article-title":"Marked differences in tissue-specific expression of chitinases in mouse and man","volume":"53","author":"Boot","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.revmed.2025.06.014_bib0785","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10545-005-0585-9","article-title":"Evaluation of three biochemical markers in the monitoring of Gaucher disease","volume":"28","author":"Vellodi","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.revmed.2025.06.014_bib0790","doi-asserted-by":"crossref","first-page":"26252","DOI":"10.1074\/jbc.270.44.26252","article-title":"Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages","volume":"270","author":"Boot","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2025.06.014_bib0795","doi-asserted-by":"crossref","first-page":"e67399","DOI":"10.1371\/journal.pone.0067399","article-title":"Quantification of chitinase mRNA levels in human and mouse tissues by real-time PCR: species-specific expression of acidic mammalian chitinase in stomach tissues","volume":"8","author":"Ohno","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2025.06.014_bib0800","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10545-005-4416-9","article-title":"Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease","volume":"28","author":"Brinkman","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.revmed.2025.06.014_bib0805","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/01.ATV.0000089329.09061.07","article-title":"Serum chitotriosidase activity is increased in subjects with atherosclerosis disease","volume":"23","author":"Artieda","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0810","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajh.10151","article-title":"Plasma chitotriosidase activity in patients with beta-thalassemia","volume":"71","author":"Altarescu","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0815","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0009-8981(03)00089-5","article-title":"Plasma chitotriosidase activity in acute Plasmodium falciparum malaria","volume":"331","author":"Barone","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.revmed.2025.06.014_bib0820","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/sj.gene.6364025","article-title":"A 24-bp duplication in exon 10\u00a0of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions","volume":"4","author":"Malaguarnera","year":"2003","journal-title":"Genes Immun"},{"key":"10.1016\/j.revmed.2025.06.014_bib0825","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","article-title":"The human chitotriosidase gene. Nature of inherited enzyme deficiency","volume":"273","author":"Boot","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2025.06.014_bib0830","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/humu.20524","article-title":"Type 1\u00a0Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring","volume":"28","author":"Grace","year":"2007","journal-title":"Human Mutation"},{"key":"10.1016\/j.revmed.2025.06.014_bib0835","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/jhg.2014.16","article-title":"Allele frequency of a 24\u00a0bp duplication in exon 10\u00a0of the CHIT1\u00a0gene in the general Korean population and in Korean patients with Gaucher disease","volume":"59","author":"Woo","year":"2014","journal-title":"J Hum Genet"},{"key":"10.1016\/j.revmed.2025.06.014_bib0840","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1007\/s00018-006-6269-2","article-title":"Chitotriosidase: the yin and yang","volume":"63","author":"Malaguarnera","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.revmed.2025.06.014_bib0845","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0850","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cca.2020.11.025","article-title":"Chitotriosidase gene polymorphisms and mutations limit the determination of chitotriosidase expression in sarcoidosis","volume":"513","author":"Csongr\u00e1di","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.revmed.2025.06.014_bib0855","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1159\/000100555","article-title":"Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis","volume":"74","author":"Bargagli","year":"2007","journal-title":"Respiration"},{"key":"10.1016\/j.revmed.2025.06.014_bib0860","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.rmed.2007.05.008","article-title":"Chitotriosidase activity in patients with interstitial lung diseases","volume":"101","author":"Bargagli","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0865","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2353\/ajpath.2010.090455","article-title":"Lung chitinolytic activity and chitotriosidase are elevated in chronic obstructive pulmonary disease and contribute to lung inflammation","volume":"176","author":"L\u00e9tuv\u00e9","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0870","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4168\/aair.2015.7.1.14","article-title":"Chitotriosidase in the pathogenesis of inflammation, interstitial lung diseases and COPD","volume":"7","author":"Cho","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.revmed.2025.06.014_bib0875","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/00365510410004092","article-title":"Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis","volume":"64","author":"Grosso","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0880","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/00365510701854975","article-title":"Chitotriosidase and soluble IL-2\u00a0receptor: comparison of two markers of sarcoidosis severity","volume":"68","author":"Bargagli","year":"2008","journal-title":"Scand Journ Clin Lab Invest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0885","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10875-012-9754-4","article-title":"Human chitotriosidase: a sensitive biomarker of sarcoidosis","volume":"33","author":"Bargagli","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0890","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2019.10.010","article-title":"Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis","volume":"500","author":"Enyedi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.revmed.2025.06.014_bib0895","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2014.02.002","article-title":"Serial chitotriosidase measurements in sarcoidosis--two-to-five-year follow-up study","volume":"108","author":"Harlander","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0900","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12931-019-1263-z","article-title":"Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis","volume":"21","author":"Bennett","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.revmed.2025.06.014_bib0905","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/00365510902829362","article-title":"Chitotriosidase activity in sarcoidosis and some other pulmonary diseases","volume":"69","author":"Ter\u010delj","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0910","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2009.09.034","article-title":"Plasma chitotriosidase and CCL18\u00a0as surrogate markers for granulomatous macrophages in sarcoidosis","volume":"411","author":"Boot","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.revmed.2025.06.014_bib0915","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8565423","article-title":"Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6","author":"Bergantini","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.revmed.2025.06.014_bib0920","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5578\/tt.20239605","article-title":"The role of serum and bronchoalveolar lavage fluid chitotriosidase activity on diagnosis, disease characteristics and prognosis of sarcoidosis","volume":"71","author":"K\u00f6yc\u00fc Buhari","year":"2023","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.revmed.2025.06.014_bib0925","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.2147\/JIR.S378357","article-title":"Pharmacological inhibition of chitotriosidase (CHIT1) as a novel therapeutic approach for sarcoidosis","volume":"15","author":"Dymek","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.revmed.2025.06.014_bib0930","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4168\/aair.2015.7.1.14","article-title":"Chitotriosidase in the pathogenesis of inflammation, interstitial lung diseases and COPD.Allergy","volume":"7","author":"Cho","year":"2015","journal-title":"Asthma Immunol Res"},{"key":"10.1016\/j.revmed.2025.06.014_bib0935","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1378\/chest.124.1.186","article-title":"Serum soluble interleukin-2\u00a0receptor measurement in patients with sarcoidosis: a clinical evaluation","volume":"124","author":"Grutters","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2025.06.014_bib0940","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0272-5231(05)70421-4","article-title":"Biochemical changes in sarcoidosis","volume":"18","author":"Costabel","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0945","first-page":"25","article-title":"High serum levels soluble interleukine-2\u00a0receptors in sarcoidosis","volume":"4","author":"Semenzato","year":"1987","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.revmed.2025.06.014_bib0950","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/17476348.2020.1751614","article-title":"Value of serum soluble interleukin-2\u00a0receptor as a diagnostic and predictive biomarker in sarcoidosis","volume":"14","author":"Schimmelpennink","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0955","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.revmed.2025.06.014_bib0960","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.rmed.2007.03.002","article-title":"Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum","volume":"101","author":"Bons","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0965","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18\u00a0FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0970","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1440-1843.2011.01966.x","article-title":"Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis","volume":"16","author":"Umeda","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.revmed.2025.06.014_bib0975","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2017.4771","article-title":"Diagnostic value of serum-soluble interleukine-2\u00a0receptor levels vs angiotensin-converting enzyme in patients with sarcoidosis-associated uveitis","volume":"135","author":"Groen-Hakan","year":"2017","journal-title":"JAMA Ophtalmol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0980","doi-asserted-by":"crossref","first-page":"e0147258","DOI":"10.1371\/journal.pone.0147258","article-title":"Interleukin-2\u00a0receptor and angiotensin-converting enzyme as markers for ocular sarcoidosis","volume":"11","author":"Gundlach","year":"2016","journal-title":"PLos One"},{"key":"10.1016\/j.revmed.2025.06.014_bib0985","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-105-4-560","article-title":"The human interleukin-2\u00a0receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses","volume":"105","author":"Greene","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib0990","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/ajrccm\/139.4.1036","article-title":"Prolonged elevations of soluble lnterleukin-2\u00a0receptors in tuberculosis","volume":"139","author":"Brown","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.revmed.2025.06.014_bib0995","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780310605","article-title":"Soluble interleukin-2\u00a0receptors in systemic lupus erythematosus","volume":"31","author":"Wolf","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2025.06.014_bib1000","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1183\/09031936.00005315","article-title":"Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency","volume":"46","author":"Verwoerd","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2025.06.014_bib1005","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1378\/chest.98.5.1125","article-title":"Serum concentration of soluble interleukin-2\u00a0receptor as a sensitive parameter of disease activity in sarcoidosis","volume":"98","author":"Keicho","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2025.06.014_bib1010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1164\/ajrccm\/137.4.759","article-title":"Elevated concentrations of soluble interleukin-2\u00a0receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis","volume":"137","author":"Lawrence","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.revmed.2025.06.014_bib1015","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.rmed.2018.02.009","article-title":"Efficacy and safety of infliximab biosimilar Inflectra\u00ae in severe sarcoidosis","volume":"138","author":"Schimmelpennink","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib1020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ajcp\/68.2.219","article-title":"Elevation of granulomatous lymph-node and serum lysozyme in sarcoidosis and correlation with angiotensin-converting enzyme","volume":"68","author":"Silverstein","year":"1977","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.revmed.2025.06.014_bib1025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/PL00007637","article-title":"Serum lysozyme levels and clinical features of sarcoidosis","volume":"177","author":"Tomita","year":"1999","journal-title":"Lung"},{"key":"10.1016\/j.revmed.2025.06.014_bib1030","first-page":"228","article-title":"Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis","volume":"59","author":"Gr\u00f6nhagen-Riska","year":"1978","journal-title":"Scand J Respir Dis"},{"key":"10.1016\/j.revmed.2025.06.014_bib1035","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1172\/JCI106387","article-title":"Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia","volume":"49","author":"Pruzanski","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2025.06.014_bib1040","first-page":"185","article-title":"Biochemical markers in sarcoidosis","volume":"24","author":"Selroos","year":"1986","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.revmed.2025.06.014_bib1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccm.2008.03.004","article-title":"Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas","volume":"29","author":"Bargagli","year":"2008","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib1050","first-page":"25","article-title":"Relationship between serum neopterin and lymphocytic alveolitis in sarcoidosis","volume":"5","author":"Blaschke","year":"1988","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.revmed.2025.06.014_bib1055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1164\/rccm.200705-742OC","article-title":"Phenotyping sarcoidosis from a pulmonary perspective","volume":"177","author":"Prasse","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib1060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/biom8030084","article-title":"YKL-40, soluble IL-2 receptor, angiotensin converting enzyme and C-reactive protein: comparison of markers of sarcoidosis activity","volume":"8","author":"Uysal","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.revmed.2025.06.014_bib1065","doi-asserted-by":"crossref","first-page":"e43588","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-production regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2025.06.014_bib1070","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","article-title":"Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis","volume":"37","author":"Ando","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2025.06.014_bib1075","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis association with disease activity","volume":"52","author":"Jeda-Hayakawa","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2025.06.014_bib1080","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.rmed.2010.02.026","article-title":"Increased expression of YKL-40, a chitinase like protein, in serum and lung patients with idiopathic pulmonary fibrosis","volume":"104","author":"Furuhashi","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib1085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.rmed.2004.09.016","article-title":"Increased serum YKL-40\u00a0in patients with pulmonary sarcoidosis - a potential marker of disease activity","volume":"99","author":"Johansen","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib1090","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1172\/JCI109442","article-title":"Evidence that increased circulating 1\u00a0alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis","volume":"64","author":"Bell","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2025.06.014_bib1095","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI111147","article-title":"Metabolism of 25-hydroxyvitamin D3\u00a0by cultured pulmonary alveolar macrophages in sarcoidosis","volume":"72","author":"Adams","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2025.06.014_bib1100","first-page":"220","article-title":"Renal sarcoidosis and hypercalcemia","volume":"32","author":"Sharma","year":"2005","journal-title":"Eur Respir J Monogr"},{"key":"10.1016\/j.revmed.2025.06.014_bib1105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MCP.0b013e328348b3cb","article-title":"How to diagnose and manage difficult problems of calcium metabolism in sarcoidosis: an evidence-based review","volume":"17","author":"Vucinic","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib1110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.rmed.2009.12.004","article-title":"Elevated 1,25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis","volume":"104","author":"Kavathia","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib1115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MNM.0000000000000431","article-title":"Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2\u00a0receptor levels and other biomarkers in patients with untreated sarcoidosis","volume":"37","author":"Kalkanis","year":"2015","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.revmed.2025.06.014_bib1120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1465-9921-14-121","article-title":"Interferon-inducible chemokines reflect severity and progression in sarcoidosis","volume":"14","author":"Su","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.revmed.2025.06.014_bib1125","doi-asserted-by":"crossref","first-page":"1800010","DOI":"10.1183\/13993003.00010-2018","article-title":"Reassessing Th1\u00a0versus Th17.1\u00a0in sarcoidosis: new tricks for old dogma","volume":"51","author":"Chen","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2025.06.014_bib1130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-gamma-producing T-helper 17.1\u00a0cells are increased in sarcoidosis and are more prevalent than T-helper type 1\u00a0cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2025.06.014_bib1135","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1378\/chest.09-1975","article-title":"Comparative evaluation of serum biomarkers in pulmonary sarcoidosis","volume":"137","author":"Miyoshi","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2025.06.014_bib1140","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1378\/chest.124.6.2119","article-title":"Study of Clara cells 16, KL-6\u00a0and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis","volume":"124","author":"Janssen","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2025.06.014_bib1145","doi-asserted-by":"crossref","first-page":"103184","DOI":"10.1016\/j.jaut.2024.103184","article-title":"Application of laboratory models for sarcoidosis research","volume":"149","author":"Bhargava","year":"2024","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.revmed.2025.06.014_bib1150","doi-asserted-by":"crossref","first-page":"2002950","DOI":"10.1183\/13993003.02950-2020","article-title":"Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis","volume":"58","author":"Vukmirovic","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2025.06.014_bib1155","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.27024","article-title":"Cerebrospinal fluid cytokine and chemokine profiles in central nervous system sarcoidosis: diagnostic and immunopathologic insights","volume":"96","author":"Mangioris","year":"2024","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2025.06.014_bib0580","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00408-023-00641-7","article-title":"Current applications of artificial intelligence in sarcoidosis","volume":"201","author":"Lew","year":"2023","journal-title":"Lung"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866325006630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866325006630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:04:36Z","timestamp":1757757876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866325006630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":116,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0248866325006630"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2025.06.014","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Place de la chitotriosidase au sein des biomarqueurs s\u00e9riques de la sarco\u00efdose\u00a0: une revue narrative de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2025.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}